Director Shareholding

GlaxoSmithKline PLC 06 January 2004 Directors' Interests I give below details of changes in the directors' interests in the Ordinary Shares and ADS Shares of GlaxoSmithKline plc. On 31 December 2003, the following Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and American Depository Shares (ADS's) in the Company through the Annual Re-investment of Dividends paid throughout 2003, as listed below: SmithKline Beecham Non-Executive Directors Retainer Fee and Share Allocation Award - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average Price (£) No. of ADS's Average Price ($) Shares Sir Christopher Hogg 30.077 12.76 Mr D McHenry 13.155 46.183 Sir Ian Prosser 30.077 12.76 Dr Lucy Shapiro 48.871 12.76 13.155 46.183 GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average Price (£) No. of ADS's Average Price ($) Shares Sir Christopher Hogg 327.877 12.76 Dr Michele Barzach 67.265 12.76 Sir Peter Job 245.375 12.76 Mr J McArthur 43.635 46.183 Mr D McHenry 29.440 46.183 Sir Ian Prosser 157.948 12.76 Dr Ronaldo Schmitz 153.805 12.76 Dr Lucy Shapiro 29.440 46.183 The Company was notified of this information on 5th January 2003. S M Bicknell Company Secretary 6th January 2004 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings